Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia: Haematologica

E. Brissot, M. Labopin, M. M. Beckers, G. Socie, A. Rambaldi, L. Volin, J. Finke, S. Lenhoff, N. Kroger, G. J. Ossenkoppele, C. F. Craddock, I. Yakoub-Agha, G. Gurman, N. H. Russell, M. Aljurf, M. N. Potter, A. Nagler, O. Ottmann, J. J. Cornelissen, J. EsteveM. Mohty

Research output: Contribution to journalArticlepeer-review

79 Citations (Scopus)
Original languageEnglish
Pages (from-to)392-399
Number of pages8
JournalHaematologica
Volume100
Issue number3
Early online date19 Dec 2014
DOIs
Publication statusPublished - Mar 2015

Keywords

  • minimal residual disease bone-marrow-transplantation chronic myeloid-leukemia 1st complete remission imatinib mesylate follow-up reduced-intensity receiving imatinib therapy improves chemotherapy

Cite this